NDC 54288-111-01 - HYOSCYAMINE SULFATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54288-111
- Requested NDC
- 54288-111-01
- Package NDCs from labels
- 54288-111-01, 54288-111-05
- Manufacturer
- BPI Labs LLC
- Effective date
- 2025-12-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYOSCYAMINE SULFATE - BPI Labs LLC | BPI Labs LLC | 2025-12-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54288-111-01 | HYOSCYAMINE SULFATE | 1 mL in 1 VIAL | INJECTION, SOLUTION | 1 | 10 | |
| 54288-111-05 | HYOSCYAMINE SULFATE | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54288-111-01 | ML - Milliliter | 54288-111 | 0017a589-20e0-4166-b053-9f0fd097047d | 1 | 2019-11-12 |
| 54288-111-05 | ML - Milliliter | 54288-111 | 2073e957-68f3-4078-adc6-3256195cbe78 | 1 | 2019-11-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 3765c251-eb14-d60f-e063-6294a90a6a4d | 2025-11-12 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37f244fd-c02f-e66a-e063-6394a90aed81 | 2025-11-12 | Warnings | 059QF0KO0R |
| STERILE WATER | WATER | Henry Schein, Inc. | f4087143-9868-4308-b96c-43657ee8ec28 | 2025-11-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Uro-MP | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE | Method Pharmaceuticals, LLC | 1e1b0dee-1a3b-4846-a212-c9febb3fc17d | 2025-10-29 | Warnings, Adverse reactions | F2R8V82B84 |
| Sterile Water | WATER | ICU Medical Inc. | 1c0bbcb7-5ed6-4ee7-b297-080d3359474e | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2025-10-27 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | Becton Dickinson and Company | cab03cda-4660-4020-a3be-bf86242ff664 | 2025-10-22 | Warnings, Adverse reactions | 059QF0KO0R |
| OSCIMIN | HYOSCYAMINE SULFATE | Larken Laboratories, Inc. | 8504adad-f6d0-4671-b655-4b62bf29a516 | 2025-10-21 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate ODT | HYOSCYAMINE SULFATE | Acella Pharmaceuticals, LLC | eef6babc-241f-40b6-b8c8-daa92bbd0a25 | 2025-10-21 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Laser Pharmaceuticals, LLC | b12f856f-7157-4aee-bf73-1fdcb4834ffc | 2025-10-17 | Warnings, Adverse reactions | F2R8V82B84 |
| OSCIMIN | HYOSCYAMINE SULFATE | Larken Laboratories, Inc. | 2d5fa637-0696-40fe-9bc1-fcb6f07a50f6 | 2025-10-16 | Warnings, Adverse reactions | F2R8V82B84 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.